- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02331784
Plasticity-based Adaptive Cognitive Remediation for Alzheimer Disease (PACR-AD)
April 17, 2019 updated by: Posit Science Corporation
The primary objective of this study is to evaluate the effects of the experimental treatment (cognitive training) further outlined in this protocol on the cognitive abilities (e.g., processing speed, attention, working memory, and executive function), brain functionality, functional status and quality of life of individuals with age-related cognitive decline as compared to a computer-based active control.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The normal aging has a devastating effect on our cognitive ability to learn and remember, on the speed with which the investigators process information, and on our ability to reason.
By 2050, nearly 14 million individuals in the US will be living with Alzheimer's disease (AD), up from 5 million in 2013.
AD is the most common cause of dementia, resulting in the loss of cognitive functions such as memory, reasoning, language, and cognitive, social, physical, and emotional control, to the extent that losses interfere with activities of daily living and necessitate continuous monitoring and care.
Many studies now show that the processing machinery of the brain is plastic and remodeled throughout life by learning and experience, enabling the strengthening of cognitive skills or abilities.
Research has shown that brief, daily computerized cognitive training that is sufficiently challenging, goal-directed and adaptive enables intact brain structures to restore balance in attention and compensate for disruptions in cognitive functioning.
The study aims to understand how our computer program can affect cognition and attention in those with aging brain.
Study Type
Interventional
Enrollment (Actual)
68
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Iowa
-
Iowa City, Iowa, United States, 52242
- University of Iowa
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years to 79 years (Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 65-79 years at the time of consent
- Fluent English speakers, to ensure reasonable results neuropsychological assessments
- Adequate sensorimotor capacity to perform the program, including visual capacity adequate to read from a computer screen at a normal viewing distance, auditory capacity adequate to understand normal speech, and motor capacity adequate to control a computer mouse
- No evidence of dementia as indicated by Montreal Cognitive Assessment (MoCA) scores >25
Exclusion Criteria:
- Diagnosis with Alzheimer's disease or related dementias
- Requiring caregiver assistance in dressing/personal hygiene
- Medical conditions predisposing to imminent functional decline
- Recent participation of computer-delivered cognitive training
- Diagnosis of an illness or condition with known cognitive consequences (e.g., schizophrenia, bipolar disorder, cancer, multiple sclerosis) will be excluded due to the confound with cognitive impairment from normal aging.
- Uncorrectable acuity greater than 20/40
- Self-reported cardiovascular disease
- Claustrophobia or any other contraindication to MRI scanning
- Inability to complete a 1-hour MRI
- Any implanted devices above the waist (e.g., cardiac pacemaker or auto-defibrillators, neural pacemaker, aneurysm clips, cochlear implant, metallic bodies in the eye or central nervous system, any form of wires or metal devices that may concentrate radio frequency fields)
- History of brain surgery; removal of brain tissue; or history of stroke.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Computerized Plasticity-based Software
Computerized Plasticity-based software training requiring a total maximum of 50 treatment sessions, 4-5 times weekly, 40 minutes each session.
|
Participants will be asked to use their assigned training program for forty minutes per session, up to five sessions per week, over 10 weeks (50 total sessions).
|
Active Comparator: Commercially available video game
Commercially available video game training.
Treatment is software based, will occur up to 50 times throughout study duration, 4-5 times per week, 40 minutes each session..
|
Participants will be asked to use their assigned video games for forty minutes per session, up to five sessions per week, over 10 weeks (50 total sessions).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in performance on global cognitive composite score
Time Frame: Baseline and at the completion of 10 weeks of training
|
Change in performance on global cognitive composite score based on the average of all normalized assessment measures.
|
Baseline and at the completion of 10 weeks of training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in brain function
Time Frame: Baseline and at the completion of 10 weeks of training
|
Change in resting state functional connectivity will be measured by resting State T2*weighted EPI-BOLD, a 10-minute task-free BOLD contrast sequence consisting of 300 volumes (TR=2000 ms/TE=30ms) at 3.4mm3 in-plane resolution and 3mm slice thickness.
Participants will be instructed to keep their eyes open and maintain attention on a central gray fixation cross on a black screen.
|
Baseline and at the completion of 10 weeks of training
|
Changes in brain structure
Time Frame: Baseline and at the completion of 10 weeks of training
|
3D T1-Weighted multi-echo MPRAGE.
Morphometric analyses will be based on this MRI sequence (not accelerated because the reliability of acceleration for multi-site studies has not yet been established).
We will achieve spatial resolution of 1 x 1 x 1 mm voxels.
|
Baseline and at the completion of 10 weeks of training
|
Changes in task-related brain activation
Time Frame: Baseline and at the completion of 10 weeks of training
|
Change in functional connectivity and brain activation will be measured while performing Flanker Task.
|
Baseline and at the completion of 10 weeks of training
|
Changes in performance on memory composite score
Time Frame: Baseline and at the completion of 10 weeks of training
|
Change in performance on memory will be measured using the composite score created by averaging the z-scores of Visual Short Term Memory, Spatial Working Memory and N-Back tasks.
|
Baseline and at the completion of 10 weeks of training
|
Changes in performance on executive function composite score
Time Frame: Baseline and at the completion of 10 weeks of training
|
Change in performance on executive function will be measured using the composite score created by averaging the z-scores for the Flanker, Stroop and Trail Making tasks.
|
Baseline and at the completion of 10 weeks of training
|
Changes in performance on processing speed composite score
Time Frame: Baseline and at the completion of 10 weeks of training
|
Change in performance on processing speed will be measured using the composite score created by averaging the z-scores of Pattern Comparison, Letter Comparison, and Digit Symbol Coding tasks.
|
Baseline and at the completion of 10 weeks of training
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Life Satisfaction
Time Frame: Baseline and at the completion of 10 weeks of training
|
Change in life satisfaction will be measured using the age-adjusted score on General Life Satisfaction Survey from NIH Tool Box.
|
Baseline and at the completion of 10 weeks of training
|
Changes in Perceived Stress
Time Frame: Baseline and at the completion of 10 weeks of training
|
Change in stress will be measured using the age-adjusted score on Perceived Stress Survey from NIH Tool Box.
|
Baseline and at the completion of 10 weeks of training
|
Changes in Self-Efficacy
Time Frame: Baseline and at the completion of 10 weeks of training
|
Change in self-efficacy will be measured using the age-adjusted score on Self-Efficacy Survey from NIH Tool Box.
|
Baseline and at the completion of 10 weeks of training
|
Changes in Olfaction
Time Frame: Baseline and at the completion of 10 weeks of training
|
Changes in olfaction will be measured using the age-adjusted score on Odor Identification Test from NIH Tool Box.
|
Baseline and at the completion of 10 weeks of training
|
Changes in Standing Balance
Time Frame: Baseline and at the completion of 10 weeks of training
|
Changes in standing balance will be measured using age-adjusted score on Standing Balance Test from NIH Tool Box.
|
Baseline and at the completion of 10 weeks of training
|
Change in Physical Activity
Time Frame: Over 10 weeks
|
Change in total score based on weekly self-report dairy about physical activity over a 10 week period.
|
Over 10 weeks
|
Change in Diet
Time Frame: Over 10 weeks
|
Change in total score based on weekly self-report dairy about diet over a 10 week period.
|
Over 10 weeks
|
Change in Social Activity
Time Frame: Over 10 weeks
|
Change in total score based on weekly self-report dairy about social activity over a 10 week period.
|
Over 10 weeks
|
Change in Functional Abilities
Time Frame: Over 10 weeks
|
Change in total score based on weekly self-report dairy about functional abilities over a 10 week period
|
Over 10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Hyunkyu Lee, Ph.D., Posit Science
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2015
Primary Completion (Actual)
April 20, 2017
Study Completion (Actual)
April 20, 2017
Study Registration Dates
First Submitted
December 18, 2014
First Submitted That Met QC Criteria
January 2, 2015
First Posted (Estimate)
January 6, 2015
Study Record Updates
Last Update Posted (Actual)
April 19, 2019
Last Update Submitted That Met QC Criteria
April 17, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PSC-PACR-AD-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Older Adults, Aging Brain
-
Laval UniversityUniversité Catholique de LouvainRecruitingAging | Older Adults | Aging WellCanada
-
University of BrasiliaCompleted
-
University of ÉvoraFoundation for Science and Technology, Portugal; Comprehensive Health Research...Completed
-
University of StirlingCompletedAging | Healthy Aging | Older Adults | AgedUnited Kingdom
-
University of California, Los AngelesThe National Council on Aging; City of Los Angeles Department of Aging; Los Angeles...Completed
-
PfizerTerminatedAging | Frail Older AdultsUnited States
-
University of CopenhagenCompleted
-
University of StirlingCompletedQuality of Life | Stress, Physiological | Aging | Healthy Aging | Older Adults | Depression, AnxietyUnited Kingdom
-
KU LeuvenCompletedHealthy Older Adults | Ill Older AdultsBelgium
-
University Ramon LlullQueen's University, Belfast; University of Southern Denmark; University of Ulm; University of Glasgow and other collaboratorsCompletedPhysical Activity | Physical Function | Sedentary Behaviour | Frail Older Adults | Biological Aging | Controlled Clinical Trials, Randomized | Exercise Referral SchemesSpain
Clinical Trials on Computerized Plasticity-based Software
-
Posit Science CorporationVA Palo Alto Health Care SystemCompletedPost Traumatic Stress Disorder | Alcohol Use DisorderUnited States
-
Posit Science CorporationVA Connecticut Healthcare System; Walter Reed National Military Medical Center and other collaboratorsCompletedTraumatic Brain InjuryUnited States
-
Posit Science CorporationWithdrawn
-
Posit Science CorporationActive, not recruiting
-
Stony Brook UniversityNational Multiple Sclerosis SocietyUnknownMultiple SclerosisUnited States
-
Posit Science CorporationWashington University School of Medicine; Spaulding Rehabilitation Hospital; VA...CompletedStroke | Acquired Brain Injury | Hemispatial NeglectUnited States
-
Posit Science CorporationHarvard Medical School (HMS and HSDM); University of IowaCompletedAge-related Cognitive DeclineUnited States
-
Posit Science CorporationCompletedHIV-associated Neurocognitive DysfunctionUnited States
-
Posit Science CorporationUniversity of Iowa; The University of Texas at DallasRecruitingAge-related Cognitive DeclineUnited States
-
Posit Science CorporationCompletedInsomnia ChronicUnited States